2Jacobson R K, Lee K C , Muglia J J, ei al. Cutaneousmanifestations of angioimmunoblastic T-cell lymphoma[J]. J Am Acad Dermatol,2013 ,69(1 ) ;e25-e26.
3Smedby K E, Baecklund E,Askling J. Malignant lympho-mas in autoimmunity and inflammation : a review of risks,risk factors, and lymphoma characteristics [ J ]. Cancer Ep-idemiol Biomarkers Prev, 2006,15( 1) :2069-2077.
4Merchant S H, Amin M B, Viswanatha D S. Morphologicand immunophenotypic analysis of angioimmunoblastic T-celllymphoma : Emphasis on phenotypic aberrancies for early di-agnosis [J]. Am J Clin Pathol, 2006,126(1) :29-38.
5Smith J L,Hodges E,Quin C T, ei al. Frequent T and Bcell oligoclones in histologically and immunophenotypical-ly characterized angioimmunoblastic lymphadenopathy[J]. Am J Pathol, 2000,156(2) :661-669.
6Attygalle A, Al-Jehani H, Diss T C,ef al. Neoplastic Tcells in angioimmunoblastic T-cell lymphoma expressCD10[J]. Blood, 2002,99(2) :627-633.
7Dupuis J, Boye K, Martin N, et al. Expression of CX-CL13 by neoplastic cells in angioimmunoblastic T-celllymphoma ( AITL) : a new diagnostic marker providingevidence that AITL derives from follicular helper T cells[J] . Am J Surg Pathol, 2006,30(4) :490-494.
8Tachibana T, Tomita N, Furuya M,et al. AberrantCD20 expression in angioimmunoblastic T-cell lymphoma[J]. Intern Med, 2011,50(5) :495-499.
9Ratajczak P, Leboeuf C , Wang L, et al. BCL2 expres-sion in CD105 positive neoangiogenic cells and tumor pro-gression in angioimmunoblastic T-cell lymphoma[ J ]. ModPathol, 2012,25(6):805-814.
10Tokunaga T,Shimada K, Yamamoto K, et al. Retrospec-tive analysis of prognostic factors for angioimmunoblasticT-cell lymphoma : a multicenter cooperative study in Ja-pan [ J ]. Blood, 2012,119(12) :3543.
